Jon Jones issues parting shot to Josh Hokit in feud: ‘Good luck little man’
UFC heavyweight champion Jon Jones fires back at Bellator fighter Josh Hokit after Hokit escalates their feud with drug-related accusations.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
Coverage from MMA Sucka reports that Bellator heavyweight Josh Hokit has escalated his ongoing feud with UFC heavyweight champion Jon Jones by introducing drug-related talk into their public exchange.
The MMA Sucka report emphasizes the cross-promotional nature of this feud, with Jones reigning as the UFC heavyweight champion while Hokit competes under the Bellator banner. The coverage highlights how Hokit's decision to bring drug-related accusations into the dispute marks a significant escalation from typical fight promotion trash talk into more serious personal allegations. The outlet frames this as a notable development in the ongoing narrative between the two heavyweights, though the coverage does not specify the exact nature of Hokit's drug-related claims or provide direct quotes beyond Jones's reported response.
The coverage does not detail the origin of their initial conflict or previous exchanges, nor does it specify whether any formal bout agreement or promotional crossover discussion has ever been contemplated between UFC and Bellator for these two athletes. The drug-related dimension introduces a layer of seriousness that goes beyond standard pre-fight hype.
What to watch next includes whether Hokit responds further to Jones's dismissal, if either promotion comments officially on the drug-related allegations raised by one of their fighters against a competitor in a rival organization, and whether this exchange leads to any formal disciplinary scrutiny or remains confined to social media and press coverage. The coverage does not indicate any scheduled fights for either man that might intersect with this feud's timeline.
Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: unsupported claims removed (73% supported) Updated 1d ago.
Quick answers
What did Josh Hokit say to escalate the feud?
Coverage states Hokit introduced drug-related talk but does not specify the exact allegations or provide direct quotes of his comments.
How did Jon Jones respond?
According to the coverage, Jones replied with 'Good luck little man' as a parting shot.
Do they fight in the same promotion?
No. Jones is the UFC heavyweight champion; Hokit competes in Bellator.
Coverage (1)
- Josh Hokit Escalates Jon Jones Feud with Drug Talk MMA Sucka · 1d ago
Topics
Related trends
Mike Perry reacts to his return to UFC, teases interest in Jorge Masvidal for first fight back
Mike Perry re-signs with the UFC after five years and immediately teases a potential matchup against Jorge Masvidal.
Jim Miller apologizes for accepting fight against Terrance McKinney after ‘complete bullsh*t’ missing weight
UFC veteran Jim Miller apologized for fighting Terrance McKinney after McKinney missed weight, while McKinney called out Conor McGregor following a first-round knockout at UFC 334.
Back from the dead? Dana White open to Kayla Harrison-Amanda Nunes rematch at 145
Kayla Harrison submitted Amanda Nunes at UFC 334, then hinted at retirement while Nunes demanded a featherweight rematch and Dana White signaled openness.
Dana White admits he was wrong about Josh Hokit after UFC 334: 'Stock went up with me'
UFC 334 events at MSG spark intense discussion as Dana White changes his view on Josh Hokit following a title bout against Ciryl Gane.
Jon Jones points out ‘craziest coincidence’ after Ciryl Gane beats Josh Hokit at UFC 334
Ciryl Gane's UFC 334 win over Josh Hokit sparks intense reactions from Jon Jones, Demetrious Johnson, Johnny Walker, and Draymond Green.
Conor McGregor calls rising star ‘biggest draw in the UFC’—besides himself
Conor McGregor called heavyweight Josh Hokit the UFC's biggest draw outside of himself after Hokit's emotional social media post about fighting for fans.